Radformation develops clinical and operational software that uses AI and specialized workflows to plan radiation treatments, ensure patient safety, and optimize revenue-cycle processes for oncology providers. Its product portfolio supports all stages of the cancer care treatment process and automates routine tasks for radiation oncology clinics. Since founding in 2016, Radformation has scaled to serve over 1,400 radiation oncology clinics across 20 countries and runs approximately 30,000 software runs per day. The company reports 100% annual revenue growth since founding. Radformation plans to expand its product portfolio to address broader workflows within cancer care, grow its customer base, and increase its international reach. The company is positioning its solutions to improve patient experience and the operational efficiency of radiation oncology providers. Radformation is an NYC-based early-stage oncology software company that leverages clinical best practices and advanced algorithms to automate the optimal treatment-plan process. Its software is compatible with a wide range of cancer treatment sites and generates optimal treatment plans in minutes. The company is led by Kurt Sysock, Alan Nelson and Elisabeth van Wie. Radformation closed $1.6M in seed financing led by Brooklyn Bridge Ventures and a group of angel investors. It intends to use the funds to hire more software engineers to build out its product offering and to add to its sales and service team to support clinical clients in the United States and abroad. The company positions its product to help clinics provide optimal treatments and avoid patient harm.

Total raised

$2M

Funding rounds

2

Latest round

Seed

Latest activity

Jun 2018